See how top analysts and institutions rate CHYM — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Arete | Initiated | Buy | $34 | 2025-09-30 |
| Deutsche Bank | Resumed | Hold | 2025-07-17 | |
| Keefe Bruyette | Initiated | Outperform | $42 | 2025-07-08 |
| Deutsche Bank | Initiated | Hold | $35 | 2025-07-07 |
| William Blair | Initiated | Outperform | 2025-07-07 | |
| Piper Sandler | Initiated | Overweight | $40 | 2025-07-07 |
| Canaccord Genuity | Initiated | Buy | $40 | 2025-07-07 |
| UBS | Initiated | Neutral | $35 | 2025-07-07 |
| JP Morgan | Initiated | Overweight | $40 | 2025-07-07 |
| Morgan Stanley | Initiated | Overweight | $39 | 2025-07-07 |
| Barclays | Initiated | Overweight | $40 | 2025-07-07 |
| Evercore ISI | Initiated | Outperform | $38 | 2025-07-07 |
| Wolfe Research | Initiated | Outperform | $38 | 2025-07-07 |
| Goldman | Initiated | Neutral | $34 | 2025-07-07 |
| Compass Point | Initiated | Neutral | $33 | 2025-07-02 |
| Seaport Research Partners | Initiated | Buy | $37 | 2025-06-30 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 4 | 6 | 5 | 0 | 0 |
| October 2025 | 4 | 6 | 4 | 0 | 0 |
| September 2025 | 4 | 6 | 4 | 0 | 0 |
| August 2025 | 4 | 5 | 4 | 0 | 0 |
The majority of institutional investors have issued a "Buy" rating for CHYM, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
